Skip to main content

Table 6 Patient characteristics of the previous studies of gefitinib readministration

From: Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis

   Response to gefitinib Response to 2nd gefitinib
Author No. of patients CR/PR/SD PD CR/PR/SD PD
Yokouchi H et al. 9 9 - 8 1
Yoshimoto A et al. 1 1 - 1 0
Yano S et al. 3 3 - 2 1
Hashimoto N et al. 1 1 - 0 1
Kurata T et al. 1 1 - 1 0
  1. CR, complete response.